Horsham, Pa.,
October 31, 2002 — NextGen Healthcare Information Systems Inc., a subsidiary of Quality Systems, Inc. (NASDAQ: QSII), today announced that Claredi has tested and certified the NextGen EPM (Enterprise Practice Management) ASC X12 837 health care claim transactions as HIPAA compliant. Both professional and institutional versions of the 837 transaction were certified.
The NextGen EPM application supports the creation of a native 837 electronic claims file without use of a translator or other third-party data conversion tool. The adoption of the X12 standard positions NextGen clients to realize the expected benefits of this element of HIPAA-driven healthcare industry standardization. NextGen EPM customers will also have the ability to seamlessly process returned 835 remittance files, and will be able to create and send electronic secondary claim files. These product features facilitate compliance with the transaction and code set requirements of the Health Insurance Portability and Accountability Act of 1996 (HIPAA).
Claredi is a commercial provider of HIPAA EDI compliance testing and certification, offering payers, providers, clearinghouses and vendors confirmation that their healthcare EDI meets the requirements of the HIPAA transactions and code sets standards. More information on Claredi is available at www.claredi.com
Quality Systems and its NextGen Healthcare Information Systems subsidiary develop and market computer-based practice management and electronic patient records systems and e-business applications for dental and medical group practices marketed under the QSI and NextGen product names. More information about QSI is available at www.qsii.com. Additional information regarding NextGen is available at www.nextgen.com.
This news release may
contain forward-looking statements, including those related to revenue and net income
that involve a number of risks and uncertainties. Among the important factors that
could impact actual results are volume and timing of systems sales and installations,
length of sales cycles and installation process; the possibility that the products
will not achieve market acceptance; seasonal patterns of sales and customer buying
behavior, the development by competitors of new or superior technologies, delays in
product development, undetected errors or bugs in software, product liability,
changing economic, political or regulatory influences on the healthcare industry,
changes in product pricing policies, competitive pressures, possible regulation of
the company's software by the U.S. Food and Drug Administration, general economic
conditions, and the risk factors detailed from time to time in Quality Systems'
periodic reports and registration statements filed with the Securities and Exchange
Commission
